Status:
WITHDRAWN
Effect of Basis™ and High Intensity Interval Training (HIIT) on Muscle Metabolism and Exercise Performance
Lead Sponsor:
Elysium Health
Collaborating Sponsors:
University of Exeter
Conditions:
Healthy
Eligibility:
MALE
18-35 years
Phase:
PHASE1
Brief Summary
This is a single-center, randomized, placebo-controlled pilot study to evaluate the effects of high intensity interval training (HIIT) and daily administration of BasisTM for 3 weeks, in 18-35 year ol...
Eligibility Criteria
Inclusion
- 18 to 35 year old males
- Body mass index between 18.5-30 kg.m-2
- Ability to give informed consent
- Recreationally active (defined in the present study as exercising once a week or more).
Exclusion
- Those regularly conducting HIIT or highly trained in endurance events (e.g. triathlete)
- Currently taking supplements known to affect metabolism (e.g. ibuprofen, stimulants, vitamins, NR)
- Taking prescribed medication
- Consuming a vegan diet
- Consuming a high fat, low carbohydrate diet
- Habitual consumption of protein and/or dairy supplements (e.g. whey protein)
- Smokers
Key Trial Info
Start Date :
February 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04050358
Start Date
February 1 2023
End Date
May 1 2023
Last Update
February 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Exeter
Exeter, United Kingdom, EX1 2LU